This article is not a substitute for medical advice, diagnosis, or treatment
If an individual has Type 2 Diabetes with established cardiovascular disease, GLP-1 Receptor Agonists can lower the risk of heart attacks, stroke, and cardiovascular death
After the FDA approved Zepbound for moderate-to-severe OSA in December 2024, most Kaiser regions added an OSA coverage pathway in 2026
If you notice these signs, take a new Ozempic pen to ensure the medication does its job correctly
Aqueous-based peptide synthesis The solid-phase synthesis process described above has dominated peptide manufacturing for decades, but as weve seen, it comes with significant challenges
Carrillo-JimenezAPuigdellvolMVilaltaAVeneroJLBrownGCStGeorge-HyslopPet alEffective knockdown of gene expression in primary microglia with siRNA and magnetic nanoparticles without cell death or inflammation